Usually the microbe S. islandicus is found in hot and acidic volcanic springs, but now the microbe has also found its way to the labs of University of Southern Denmark. Here researchers have for the first time showed that the exotic microbe is capable of delivering drugs to the human body.
The microbe S. islandicus has a strange and unique talent for thriving in acidic environments. This talent would allow the microbe to safely pass through the human stomach, where harsh acidic conditions rule, and this makes the microbe interesting for scientists working with delivering drugs to the human body.
"One of the major challenges in pharmacy is to find ways to carry and protect drugs on their passage through the stomach. Many drugs may be absorbed through the intestines, so it would be a great help to be able to transport drugs safely through the stomach to the intestines", explains Sara Munk Jensen, Ph.D. student at both the Nordic Center for Earth Evolution (NordCEE), Department of Biology and the Department of Physics, Chemistry and Pharmacy, University of Southern Denmark (SDU).
Transport and protect drugs
Jensen has just completed her Ph.D. work on how to use lipids from the cell membranes of extremophilic microorganisms to design drug carriers that transport and protect drugs in the human body.
This is relevant for different drugs as growth hormones, vaccines and insulin. Many diabetics need to daily inject insulin directly into their body, and they would benefit greatly by taking insulin in a tablet instead. Not only is it easier to take a tablet than inject; when insulin is absorbed from the small intestine it is released into the body in a more natural way than when injected, and this has the potential to improve the patient's treatment.
They love it hot
Here enters the acid-loving microbe S. islandicus the scene. S. islandicus is a microorganism, which resembles bacteria, but it is just as different from a bacterium as humans are. S. islandicus is an extremophilic archaeon, meaning that it loves extreme conditions. Some extremophile archaea love to live in oxygen-free environments, others in saline environments, and S. islandicus requires an environment that is 75-80 degrees Celsius hot and has a pH of 2-3. These living conditions are found in volcanic springs in places like Iceland, Italy, Russia and North America.
Jensen and her colleagues now report in the journal International Journal of Pharmaceutics that they have managed to use S. islandicus to construct a nano-capsule that can transport drugs safely through the stomach.
Loading molecules with dye
The researchers isolated lipids from the cell membrane of S. islandicus in the laboratory and used these to construct liposomes (synthetic fat capsules). Liposomes are available in many different forms - some are e.g. used in cosmetics to transport nourishing substances into the skin. After construction, the new molecules were loaded with a dye and placed in solutions equivalent to the acidic environment in the stomach. After one and a half hours it was time to see if some of the liposomes had survived the exposure and if they still retained their content of dye. One and a half hours app. equals the time that a tablet must be able to withstand the hostile environment of the stomach before natural peristaltics pushes it forward to the intestines.
Some of the liposomes in the experiment were destroyed -- but not all. Ca. 10 pct. survived the strong acidic solution and still contained the dye after one and a half hour.
Jensen is satisfied with this result:
"We started with a completely crude extract of membrane molecules from S. islandicus. Normally, rather pure compounds are employed when making liposomes, but here I took all the fat molecules to see how far you can get with crude, non-purified material. If 10 pct. of the liposomes created on this basis can survive, then it is plausible that even more will survive if we begin to purify the molecules", explains Jensen.
She believes that some 85 pct. the liposomes need to survive the journey through the stomach before drug companies can start developing oral peptide-drugs like insulin, vaccines, etc.
What did the researchers do in the lab?
S. islandicus was grown for four days at 75 degrees Celsius. The researchers isolated all the cell-membrane molecules from the culture and combined them with conventional phospholipids (special fats from egg yolk or soybean oil) and cholesterol in order to make liposomes. The mixture was: 18 pct. S. islandicus fat molecules and 78 pct. phospholipids/cholesterol. The constructed liposomes were loaded with a dye, so that the researchers could keep track of whether the liposomes would last or be destroyed when exposed to bile salts from gastric juice. The liposomes were tested at a low and a high bile salt concentration. In the low concentration 75 pct. of the liposomes were still intact after 1.5 hours. But only 10 pct. were still intact at the high concentration. Both the low and high concentrations are within the range that is natural in a normal human stomach, namely 4 and 8 mM (one thousandth of the number of molecules per liter). In fact, the concentration in normal healthy individuals varies between 0.3 and 9.6 mM.
Ref International Journal of Pharmaceutics, Volume 493, Issues 1-2, 30 September 2015, Pages 63-69. Liposomes containing lipids from Sulfolobus islandicus with state intestinal bile salts: An approach to oral drug delivery? Sara Munk Jensena, b, Camilla Jahn Christensenb, 1, Julie Maria Petersenb, 1, Alexander H. Treuscha, Martin Brandl, b. a Department of Biology and Nordic Center for Earth Evolution, University of Southern Denmark. b Department of Physics, Chemistry and Pharmacy, University of Southern Denmark.
Photos S. islandicus in its natural environment on the Kamchatka peninsula (credit Visions of Kamchatka) + photo of S. islandicus grown in SDU's laboratory (credit Sara Munk Jensen).
Sara Munk Jensen
Birgitte Svennevig | EurekAlert!
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences